AlzeCure Receives a USD 10 Million Upfront Payment and Completes Initial Transaction with Lilly

August 18, 2026 4:15 AM

AlzeCure Pharma AB ("AlzeCure" or "The Company")(STO:ALZCUR)(FRA:AC6) , which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, announced today that it has now received the full upfront payment of USD 10 million from the American pharmaceutical company Eli Lilly. The payment is being made pursuant to the collaboration and licensing agreement for the Alzheimer's project Alzstatin, including the...

Read more

Bioz and Xenocs Improve Researcher Product Evaluation Through On-Page Publication Insights

August 18, 2026 4:00 AM

Bioz, Inc., a trusted scientific validation platform that transforms peer-reviewed publications into meaningful product evidence for suppliers and researchers, announced its partnership with Xenocs, a global provider of advanced X-ray scattering solutions for materials characterization.Through the implementation of Bioz Badges across its product detailed pages, Xenocs is giving researchers direct access to publication-backed evidence as they...

Read more

The Next Phase of Probiotics: What Will Drive Industry Growth and Consumer Value？

August 17, 2026 11:45 PM

In the early stages of market development, success in probiotics was often measured by strain counts and viability claims. As the market matures in 2026, however, competitive advantage is increasingly defined by scientific validation, manufacturing capability, application versatility, and global service.Against this backdrop, the probiotics industry is undergoing a broader transformation driven by higher expectations for scientific rigor,...

Read more

What if DEA's Own ALJ Hearing Record Undercuts Marijuana Rescheduling?

August 17, 2026 10:25 PM

The federal marijuana rescheduling hearing has concluded, and the proceeding has now entered its most consequential phase: Administrative Law Judge Derek Julius must determine what the evidentiary record actually supports. The public debate has largely assumed only two possible outcomes - Schedule I or Schedule III. But the record may support a third: Schedule II. More importantly, whichever recommendation Judge Julius makes, the government may...

Read more

EsteFavor Clinic Outlines Advanced Precision Protocol for Hair Transplantation in Istanbul

August 17, 2026 5:24 PM

As Turkey remains the world's leading destination for hair restoration, EsteFavor Clinic has detailed its technical protocol designed to address the variance between standard and high-density hair transplant outcomes. Recognized as the "Most Successful Hair Transplant Clinic" at the International Istanbul Awards in February 2026, the Istanbul-based clinic centers its methodology on graft survival rates, physician-led execution, and anatomical...

Read more

Tradesman Nutrition Reviews Highlight Why Better Sleep Is Becoming a Priority for Workers With Physically Demanding Jobs

August 17, 2026 3:10 PM

For many tradesmen, getting enough sleep has traditionally taken a back seat to early starts, long shifts, and physically demanding work. However, Tradesman Nutrition reviews suggest that more blue-collar workers are beginning to view quality sleep as an important part of staying productive, recovering after work, and preparing for the next day.Tradesman Nutrition, a supplement company that formulates products specifically for working men, says...

Read more

Vive Concierge Co-Founder Dwayne Hall's Health Equity Work Advances in Sweeping 2026 Senate Bill

August 17, 2026 12:00 PM

Vive Concierge, one of the nation's only minority- and women-founded virtual care companies, welcomed the introduction of the Health Equity and Accountability Act (HEAA) of 2026. Led in the Senate by U.S. Sen. Alex Padilla, D-Calif., the comprehensive legislation seeks to reduce health disparities and expand access to affordable, culturally responsive care.The legislation includes an "Equitable Health Care for All" section that carries forward...

Read more

CVS Health: Mental Health Can Shape Heart Health Outcomes

August 17, 2026 10:00 AM

Originally published on CVS Health CompanyKey pointsBehavioral health and heart health are deeply interconnected.Depression, anxiety and chronic stress can raise major cardiovascular event risk by ~35%, while cardiovascular patients face higher rates of depression and anxiety.Heart conditions and mental health should be treated together for holistic patient care.Heart disease remains the leading cause of death in the United States, claiming more...

Read more

Sharecare Launches AskMD Nationwide to Turn Any Health Question into a Personalized Plan

August 17, 2026 9:30 AM

Sharecare has announced that AskMD, its AI-powered health navigation experience grounded in each individual's medical history, health plan, and location, is available nationwide. Designed to turn a person's health question into a clear next step, AskMD is free on the App Store, Google Play, and the web, as well as through the Medicare App Library.While people are not short on health information, they are often overwhelmed by it, unsure of its...

Read more

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

August 17, 2026 9:00 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today reported second quarter 2026 financials...

Read more

Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

August 17, 2026 8:30 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2,293,608 shares of common stock (or pre-funded warrants in lieu thereof), series E warrants to purchase up to 2,293,608 shares of common stock and short-term series F warrants to purchase up to 2,293,608 shares of...

Read more

LEAD Launch Leaves Accountable Care Technology Buyers Little Time for a Wrong Decision, Q3 Study

August 17, 2026 8:20 AM

Black Book Market Research today announced LEAD Readiness 2027: The ACO Technology Market's Ten-Year Test, a 77-page report assessing whether accountable care organizations and their technology partners can support the Centers for Medicare & Medicaid Services' Long-term Enhanced ACO Design Model through 2036.The analysis encompasses 244 executive and operating-leader records across eight organization types: 54 integrated delivery networks or...

Read more

VOKA Wins Platinum at The dotCOMM Awards 2026

August 17, 2026 7:35 AM

VOKA, a medical visualization company specializing in 3D healthcare content, has received a Platinum dotCOMM Award 2026 for its animation "Saving a Tooth: Root Canal Treatment in 3D." The project was recognized in the competition for its combination of scientific accuracy, visual storytelling, and innovative approach to medical education. The Platinum Award is the highest recognition presented by dotCOMM Awards and honors projects that...

Read more

BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline

August 17, 2026 6:40 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to provide a comprehensive update on the progress of its proprietary sublingual thin-film drug delivery pipeline. The Company continues to advance multiple pharmaceutical development programs, including Cladribine for multiple sclerosis, autoimmune disease expansion, Everolimus and...

Read more

Ascelia Pharma Announces FDA Has Scheduled Type A Meeting for Orviglance NDA on September 9, 2026

August 17, 2026 6:10 AM

Ascelia Pharma AB (publ) (STO:ACE), a biotech company focused on improving the lives of people living with rare cancer conditions, today announced that the U.S. Food and Drug Administration (FDA) has scheduled a Type A meeting for September 9, 2026 to discuss the Complete Response Letter (CRL) issued on July 2, 2026 regarding the New Drug Application (NDA) for Orviglance®.The meeting follows FDA's acceptance of the Company's Type A meeting...

Read more

MMJ Federal Challenges Put Trump Administration's Marijuana Rescheduling Shortcut at Risk

August 16, 2026 11:05 AM

MMJ International Holdings, Inc. ("MMJ") today addressed a growing misconception surrounding the administration's accelerated marijuana and hemp policies: because those policies remain in effect, MMJ's federal challenges supposedly are not standing in their way. That conclusion mistakes implementation for legal finality.Attorney General Order No. 6754-2026 is presently operating. Certain state-licensed medical marijuana operators are claiming...

Read more

Revive Therapeutics Reports Grant of Options

August 14, 2026 6:50 PM

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(Frankfurt:31R), a life sciences company focused on the research and development of therapeutics for biodefence and pandemic preparedness, today announced the Board of Directors of Revive has authorized the grant of an aggregate of 15,500,000 incentive stock options to key members of our team, including directors, officers, and consultants. The stock options have an...

Read more

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026

August 14, 2026 5:25 PM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today announced that its board of directors...

Read more

Avologi Reviews 2026: Is Avologi Good? FDA Records, Customer Experiences, Technology and What Buyers Should Know

August 14, 2026 5:07 PM

Consumers searching "Avologi reviews," "is Avologi good?", "does Avologi work?" or "is Avologi a scam?" will find customer experiences, retailer complaints and brand claims. The best way to assess Avologi is to separate verifiable facts from individual experiences. The short answer: Avologi is a legitimate premium at-home skin-technology brand with specific FDA-cleared Class II devices, hundreds of public customer reviews, defined warranty...

Read more

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

August 14, 2026 5:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended June 30, 2026 and will have a conference call to present the Financial Results on August 17, 2026 at 8:30 am Eastern Time.Quarter Ended June 30, 2026...

Read more